Lake Street raised the firm’s price target on NeuroPace to $20 from $17 and keeps a Buy rating on the shares. Q4 “closed out an exceptional year for NeuroPace,” says the analyst, who raised the firm’s target based on what the firm calls “the continued impressive execution and favorable outlook.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NPCE:
- NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
- NPCE Earnings this Week: How Will it Perform?
- NeuroPace price target raised to $16 from $9 at Wells Fargo
- NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
- NeuroPace Announces Chief Legal Officer Irina Ridley’s Departure
